Can cytidine deaminase be used as predictive biomarker for gemcitabine toxicity and response?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Can cytidine deaminase be used as predictive biomarker for gemcitabine toxicity and response?

Published:2019-04-23 Issue:6 Volume:85 Page:1213-1214
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Peters Godefridus J.¹^ORCID,Giovannetti Elisa¹²,Honeywell Richard J.¹,Ciccolini Joseph³

Affiliation:

1. Laboratory Medical OncologyAmsterdam University Medical Center, location VUmc, Cancer Center Amsterdam Amsterdam The Netherlands

2. Cancer Pharmacology Lab, AIRC Start‐Up UnitUniversity of Pisa Pisa Italy

3. SMARTc Unit, CRCM Inserm U1068 Aix Marseille Université, and La Timone University Hospital of Marseille Marseille France

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.13921

Reference10 articles.

1. Pharmacokinetics and pharmacogenetics of Gemcitabine as a mainstay in adult and pediatric oncology: an EORTC-PAMM perspective

2. Severe Drug Toxicity Associated with a Single-Nucleotide Polymorphism of the Cytidine Deaminase Gene in a Japanese Cancer Patient Treated with Gemcitabine plus Cisplatin

3. Prolonged fixed dose rate infusion of gemcitabine with autologous haemopoietic support in advanced pancreatic adenocarcinoma

4. Correlation Between Cytidine Deaminase Genotype and Gemcitabine Deamination in Blood Samples

5. Determination of the interindividual variability in serum cytidine deaminase activity of patients with solid tumors;Cohen R;Br J Clin Pharmacol,2019

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytidine deaminase enzyme activity is a predictive biomarker in gemcitabine-treated cancer patients;Cancer Chemotherapy and Pharmacology;2023-09-05

2. Nucleoside-based anticancer drugs: Mechanism of action and drug resistance;Biochemical Pharmacology;2023-09

3. Genetic Variants in the Mitochondrial Thymidylate Biosynthesis Pathway Increase Colorectal Cancer Risk;Current Oncology;2023-08-30

4. CD44-targeting hydrophobic phosphorylated gemcitabine prodrug nanotherapeutics augment lung cancer therapy;Acta Biomaterialia;2022-06

5. Slower degradation rate of cytarabine in blood samples from acute myeloid leukemia by comparison with control samples;Cancer Chemotherapy and Pharmacology;2020-09-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3